Other methodologies have been devised to locally deliver chemotherapeutics into the brain parenchyma or the tumor aiming to bypass the BBB, avoiding the need to overcome the ABC transporters acting as gatekeepers and diminish the systemic toxicity (Figure 4C). Here, ABCG2 is linked to neoplasm.